Detection, Prevention, and Intelligent Agents are the Keys to Effectively Treating and Managing the Stages Inherent in all Chronic Disease

Artificial intelligence (AI) and sensor technology used in implantable and wearable devices and managed care solutions use smart, natural language-based agents to help clinicians and patients with chronic disease management. New technologies enabling data generation by the patient will increase the data volume, which will improve timely information and education for patients and doctors in personalizing therapy. Algorithmic support and insights based on data gathered by sensors and machine learning can give individuals more day-to-day control of their disease and remove the guesswork from daily disease management.

Moderator: Rick Berenson, CEO, Thermalin
Rick co-founded Thermalin, which is developing the StampPump – a postage-stamp-sized, wearable, intelligent glucose management system for people with T1 and T2 diabetes. As a connected sensor platform, StampPump will deliver continuous metabolic telemetry that, with the assistance of machine learning algorithms, will enable physicians to better coach diabetes patients and fine-tune their glucose control algorithms. Rick raised the funding, built the scientific and business teams, and drives the company’s strategy. Rick received a JD-MBA from Harvard Business and Law Schools in 1984, then worked for Bell Laboratories and an AI startup before joining McKinsey & Company. He subsequently became a serial entrepreneur who has previously launched and financed multiple life science organizations.

Zohar Beeri, Chairman, Novotalk
Zohar is an executive and advisor in the digital health space. He serves as the chairman of Novotalk, a company that provides the first end-to-end digital on-demand therapy for people with speech disorders. He has significant executive, business development, and marketing experience in roles he held in Israel and the US, with companies such as Forrester Research, Qbit Corp., System Models, Giga Information Group, Coca-Cola, and more. Zohar holds a BSc from the Israel Institute of Technology and an MBA from Tel-Aviv University, focusing on information technology. As a volunteer unit commander (res.) in the IDF’s Homefront Command, he is currently spending part of his time fighting the spread of the COVID-19 virus in the community.

Paul Pyzowski, Founder & CEO, Altimate Health
Paul Pyzowski is the founder and CEO of Altimate Health. Altimate is leading the development of precision psychiatry, applying data science to identify and guide treatment for patients with psychiatric and other behavioral health disorders. Paul has a diverse entrepreneurial and executive background that includes Parkinson’s disease therapeutics, therapies for pediatric epilepsy, rapid DNA sequencing, clinical laboratories for addiction medicine, and computational physics. BSEE from Carnegie-Mellon, MBA from the Institute for Management Development in Switzerland.

Kim Shah, MBA, CEO, KnowYourMeds
Shah was most recently Global Director of Marketing for the Informatics Software business within Thermo Fisher Scientific, a $20 Billion company whose mission is to enable their customers to make the world healthier, cleaner and safer. During his career, Shah has held executive level positions at a number of high tech companies such as Lotus Development, Micrografx and Inso Corporation. Shah is an experienced Marketing Executive with a demonstrated history of working in the research industry. Skilled in Product Management, Advertising, Enterprise Software, Sales, Entrepreneurship, and Customer Relationship Management (CRM). Strong marketing professional with an MBA focused in Business Administration from MIT Sloan School.

Karolina Starczak, MS, CEO, Nutrimedy
Karolina is currently the CEO of Nutrimedy, a digital health solution focused on transforming clinical nutrition care in oncology, heart failure, kidney disease, and inflammatory bowel disease. As a registered and licensed clinical dietitian, Karolina incorporates her multi-dimensional background in healthcare to uncover innovative solutions aimed at addressing cost drivers and improving health outcomes. Over the past 15 years, her career evolved from the emergency services field to digital startups and workplace wellness. From small local employers to Fortune 500 companies, Karolina has led and designed data-driven, award-winning programs that improve employee wellbeing and help curtail future healthcare spend. Karolina received her BS in Nutrition and Food Science from Montclair State University, completed her post-baccalaureate dietetic residency at Rutgers University, and completed her Master in Healthcare Leadership at Brown University.